ClearView HD intraocular lens (IOL)
Lenstec, Inc. · Decision date Oct 23, 2026
What did the FDA approve?
The FDA recorded an approval decision on 2026-10-23 for P200020/S013, a supplement to the ClearView™ HD intraocular lens (IOL) held by Lenstec, Inc. The supplement was filed under the Normal 180 Day Track with the stated reason Change Design/Components/Specifications/Material, and the device sits in the multifocal intraocular lens category (product code MFK) within the ophthalmic specialty.
The recorded statement describes the supplement as covering the ClearView™ HD IOL as a combination of the haptic design of the ClearView™ 3 IOL with the optical design of the Softec HD IOL. That describes a design change to the lens rather than a new approval of an entire system. The source record does not include supporting documents, so the specific optical or haptic parameters changed, and any clinical data reviewed, remain unknown.
FDA approval order statement
approval for the ClearView HD Intraocular Lens (IOL) as a combination of the haptic design of the ClearView 3 IOL with the optical design of the Softec HD IOL
- Regulatory pathway
- PMA supplement
- Supplement type
- Normal 180 Day Track
- Clinical specialty
- Ophthalmic
- Decision date
- Oct 23, 2026
- FDA change category
- Change Design/Components/Specifications/Material
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P200020/S013
- Regulatory pathway
- PMA supplement
- Applicant
- Lenstec, Inc.
- Product code
- MFK
- Decision code
- APPR
- Decision date
- Oct 23, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Lens, multifocal intraocular.
- Applicant
- Lenstec, Inc.
- Product code
- MFK
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P200020. Subsequent supplements may change the device or its indications.
FDA decision timeline
P200020 · Original PMA
SBL-3 Multifocal Intraocular Lens
P200020/S013 received
Application receipt date recorded by FDA.
P200020/S013 · FDA decision
Normal 180 Day Track
Timeline entries are records held by MedtechLedger for P200020. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P200020
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Lenstec, Inc. | PMA approval | Jul 22, 2022 | FDA |
Explore the linked device profile
Other records with product code MFK
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Bausch + Lomb, Inc. | PMA supplement | Oct 23, 2026 | FDA | |
TECNIS Multi-focal 3-pc, Model ZMA00P080010/S032 | Johnson & Johnson Surgical Vision, Inc. | PMA supplement | Oct 19, 2026 | FDA |
| Bausch + Lomb, Inc. | PMA supplement | Oct 14, 2026 | FDA | |
| Bausch + Lomb, Inc. | PMA supplement | Sep 30, 2026 | FDA | |
| Rayner Intraocular Lenses , Ltd. | PMA supplement | Sep 24, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Lenstec, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 1765 Commerce Ave. N, St. Petersburg, FL, 33716
Sources and methodology
- Original FDA record: P200020/S013
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


